These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 34743935)
21. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells. Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400 [TBL] [Abstract][Full Text] [Related]
22. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling. Liu B; Li X; Li C; Xu R; Sun X Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of LINC00886 facilitates epithelial-mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma. Dong Z; Yang L; Lu J; Guo Y; Shen S; Liang J; Guo W Clin Exp Metastasis; 2022 Aug; 39(4):661-677. PubMed ID: 35616822 [TBL] [Abstract][Full Text] [Related]
24. ZEB1 induced miR-99b/let-7e/miR-125a cluster promotes invasion and metastasis in esophageal squamous cell carcinoma. Ma J; Zhan Y; Xu Z; Li Y; Luo A; Ding F; Cao X; Chen H; Liu Z Cancer Lett; 2017 Jul; 398():37-45. PubMed ID: 28408353 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of nicotinamide N-methyltransferase inhibits migration and epithelial-mesenchymal transition of esophageal squamous cell carcinoma via Wnt/β-catenin pathway. Cui Y; Zhang L; Wang W; Ma S; Liu H; Zang X; Zhang Y; Guan F Mol Cell Biochem; 2019 Oct; 460(1-2):93-103. PubMed ID: 31278587 [TBL] [Abstract][Full Text] [Related]
26. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation. Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885 [TBL] [Abstract][Full Text] [Related]
27. SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer. Wei S; Sun S; Zhou X; Zhang C; Li X; Dai S; Wang Y; Zhao L; Shan B Carcinogenesis; 2021 Feb; 42(2):315-326. PubMed ID: 33095847 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA‑485‑5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin‑1 and inhibits the epithelial‑mesenchymal transition. Zhao R; Shan Y; Zhou X; Zhang C; Zhao R; Zhao L; Shan B Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846817 [TBL] [Abstract][Full Text] [Related]
29. The transcription factor c-Jun regulates Smad4 expression by upregulating pre-miR-183 expression to promote invasion and metastasis of esophageal squamous cell carcinomas. Xu X; Zheng L; Hang N; Zhu G; Mao W; Fan Y; Tao K In Vitro Cell Dev Biol Anim; 2020 Aug; 56(7):550-558. PubMed ID: 32886291 [TBL] [Abstract][Full Text] [Related]
30. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition. Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728 [TBL] [Abstract][Full Text] [Related]
31. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409 [TBL] [Abstract][Full Text] [Related]
32. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis. Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of Ubiquitin-Specific Protease 14 (USP14) Inhibits the Proliferation and Tumorigenesis in Esophageal Squamous Cell Carcinoma Cells. Zhang J; Zhang D; Sun L Oncol Res; 2017 Jan; 25(2):249-257. PubMed ID: 27629392 [TBL] [Abstract][Full Text] [Related]
34. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation. Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma. Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869 [TBL] [Abstract][Full Text] [Related]
36. Perfluorooctane sulfonate (PFOS) triggers migration and invasion of esophageal squamous cell carcinoma cells via regulation of Zeb1. Liu Y; Li J; Ding H; Ge D; Wang J; Xu C Drug Chem Toxicol; 2022 Nov; 45(6):2804-2813. PubMed ID: 34732098 [TBL] [Abstract][Full Text] [Related]
37. WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade. Yu X; Mao R; Feng W; Zhao Y; Qin J; Yang Y; Wang A; Shi Z Exp Cell Res; 2021 Dec; 409(1):112871. PubMed ID: 34672999 [TBL] [Abstract][Full Text] [Related]
38. MYH9 promotes cell metastasis Yang B; Liu H; Bi Y; Cheng C; Li G; Kong P; Zhang L; Shi R; Zhang Y; Zhang R; Cheng X Int J Med Sci; 2020; 17(13):2013-2023. PubMed ID: 32788880 [TBL] [Abstract][Full Text] [Related]
39. Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism. Zhang HF; Alshareef A; Wu C; Li S; Jiao JW; Cao HH; Lai R; Xu LY; Li EM Oncotarget; 2015 Oct; 6(30):28949-60. PubMed ID: 26334393 [TBL] [Abstract][Full Text] [Related]